Stay updated with breaking news from Adaptive. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The new technology provides commercial support for the broadest range of languages ever supported, potentially reaching 6.5 billion native speakers. Translated, a global leader in language translation
At least 1,000 volunteers are needed to ensure a safe, fun race—and keep everything running on time.
FDA confirms Type-C meeting date of 7th June 2023 for Phase 2/3 adaptive study of Lupuzor™ in lupus 20th April 2023 - 10:20 am ImmuPharma PLC , the specialist drug... | April 20, 2023
Civil Aviation Minister Jyotiraditya Scindia invited industry players from the European Union (EU) to become a part of the fastest-growing aviation market in the world as the two day EU-India Aviation Summit began on Thursday in New Delhi.
Invir.IO® based oncolytic virus TG6050, is armed with IL-12 and an anti-CTLA4 antibody. A Phase I trial (Delivir) recently started enrolling patients with advanced non-small cell lung cancer (NSCLC)